Evidence-based Consensus On The Use Of Sacubitril Valsartan For Heart Failure Management In India

被引：0

作者：

Sawhney, Jitendra ^{[1
]}

Vasudevan, Karthik ^{[2
]}

Shashikanth, T. ^{[3
]}

Das, Vashisth ^{[4
]}

Raghu, K. ^{[5
]}

Goyal, Naresh ^{[6
]}

Rastogi, Vishal ^{[7
]}

Shrivastava, Sameer ^{[8
]}

Singh, Balbir ^{[9
]}

Mehta, Ashwani ^{[1
]}

Suresh, P. V. ^{[10
]}

Ranjit, G. ^{[11
]}

Kumar, Manoj ^{[9
]}

Jain, Priyank ^{[12
]}

Pandey, Anand ^{[13
]}

机构：

[1] Sir Gangaram Hosp, New Delhi, India

[2] Manipal Hosp, Bangalore, Karnataka, India

[3] Yashoda Hosp, Hyderabad, India

[4] Chinmaya Hrudayalaya, Bangalore, Karnataka, India

[5] Care Hosp, Hyderabad, India

[6] Fortis Hosp, Shalimar Bagh, New Delhi, India

[7] Fortis Escorts, New Delhi, India

[8] Max Hosp, New Delhi, India

[9] Max Hosp, Delhi, India

[10] Narayana Hrudayalaya Inst Med Sci, Bangalore, Karnataka, India

[11] Century Hosp, Hyderabad, India

[12] DNS Hosp, Indore, India

[13] Dharam Shila Narayana Superspecial Hosp, New Delhi, India

来源：

JOURNAL OF CARDIAC FAILURE | 2024年 / 30卷 / 01期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

284

引用

页码：240 / 240

页数：1

共 50 条

[21] Impact of Sacubitril/Valsartan on Patient Outcomes in Heart Failure: Evidence to Date
Akbar, Sara
Kabra, Nitin
Aronow, Wilbert S.
THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2020, 16 : 681 - 688
[22] An Expanded Heart Failure Indication for Sacubitril/Valsartan Evolving the Evidence Bar
Yancy, Clyde W.
JAMA CARDIOLOGY, 2021, 6 (12) : 1357 - 1358
[23] Health and Economic Evaluation of Sacubitril-Valsartan for Heart Failure Management
Bhatt, Ankeet S.
Vaduganathan, Muthiah
Claggett, Brian L.
Fonarow, Gregg C.
Packer, Milton
Pfeffer, Marc A.
Shah, Sanjiv J.
Shen, Xian
Cristino, Joaquim
Mcmurray, John J. V.
Solomon, Scott D.
Gaziano, Thomas A.
JAMA CARDIOLOGY, 2023, 8 (11) : 1041 - 1048
[24] Management of a patient with heart failure by sacubitril/valsartan: improvement of functional capacity
Paolini, Carla
Perrone, Cosimo
Pellizzari, Cristina Ada
Randon, Maria Luisa
Bilato, Claudio
CURRENT MEDICAL RESEARCH AND OPINION, 2019, 35 : 7 - 8
[25] Sacubitril/Valsartan: Practice Changing Guideline in the Management of Congestive Heart Failure
Karim, Muhammad Arsalan
Siddiqui, Hafiz Umair
Ullah, Saad
Khan, Noman Ahmad Jang
JCPSP-JOURNAL OF THE COLLEGE OF PHYSICIANS AND SURGEONS PAKISTAN, 2017, 27 (11): : 733 - 733
[26] The neprilysin pathway in heart failure: a review and guide on the use of sacubitril/valsartan
Jhund, Pardeep S.
McMurray, John J. V.
HEART, 2016, 102 (17) : 1342 - 1347
[27] Sacubitril/Valsartan for the Prevention and Treatment of Postinfarction Heart Failure: Ready to Use?
Del Buono, Marco G.
Damonte, Juan, I
Trankle, Cory R.
Bhardwaj, Hem
Markley, Roshanak
Turlington, Jeremy
Van Tassell, Benjamin W.
Salloum, Fadi N.
Abbate, Antonio
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2021, 78 (03) : 331 - 333
[28] USE OF VALSARTAN-SACUBITRIL IN ELIGIBLE SYSTOLIC HEART FAILURE PATIENTS
Dhamija, Yashu
Kaelber, David
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2020, 75 (11) : 765 - 765
[29] Use of sacubitril/valsartan in acute decompensated heart failure: a case report
Bell, Taison D.
Mazer, Adrien J.
Miller, P. Elliott
Strich, Jeffrey R.
Sachdev, Vandana
Wright, Mary E.
Solomon, Michael A.
ESC HEART FAILURE, 2018, 5 (01): : 184 - 188
[30] Heart failure features and sacubitril/valsartan effects
Malfatto, Gabriella
Villani, Alessandra
Parati, Gianfranco
JOURNAL OF CARDIOVASCULAR MEDICINE, 2021, 22 (03) : 234 - 235

← 1 2 3 4 5 →